Med4: Kankeronderzoek
Dit Expertpanel omvat voornamelijk en vooral basisonderzoek waarin de ontstaans- en evolutiemechanismen van kanker (oncopathogenese) centraal staan, toegepast en klinisch kankeronderzoek, studie van kankertherapieën, inclusief immunotherapie.
|
Naam |
Instelling |
|
Voorzitter |
|
|
Bonnet Dominique |
The Francis Crick Institute |
|
Leden |
|
|
Brito Maria A. |
University of Lisbon |
|
Gartland Allison |
University of Sheffield |
|
Milliat Fabien |
French Institute for Radiation Protection and Nuclear Safety |
|
Quackenbush John |
Harvard TH Chan School of Public Health |
|
Pawelec Graham |
University of Tübingen |
|
Ricci Jean-Ehrland |
INSERM |
|
Rooman Ilse |
VUB |
|
Sanders Niek |
UGent |
|
Villunger Andreas |
Medical University of Innsbruck |
|
Naam |
Instelling |
|
Voorzitter |
|
|
Bonnet Dominique |
The Francis Crick Institute |
|
Leden |
|
|
Bertolotto Corine |
Côte d'Azur University / INSERM |
|
Brito Maria A. |
University of Lisbon |
|
De Grève Jacques |
VUB |
|
Desmedt Christine |
KU Leuven |
|
Fonteyne Valérie |
UGent |
|
Gartland Allison |
University of Sheffield |
|
Luo Jun |
John Hopkins University |
|
Milliat Fabien |
French Institute for Radiation Protection and Nuclear Safety |
|
Pawelec Graham |
University of Tübingen |
|
Quackenbush John |
Harvard TH Chan School of Public Health |
|
Ricci Jean-Ehrland |
INSERM |
|
Villunger Andreas |
Medical University of Innsbruck |
|
Naam |
Instelling |
|
Voorzitter |
|
|
Duda Dan |
Massachusetts General Hospital |
|
Leden |
|
| Allen Irving |
Virginia Tech |
| Butterworth Karl |
Queen’s University of Belfast |
|
De Wever Olivier |
Universiteit Gent |
|
Gevaert Olivier |
Stanford University |
|
Haustermans Karin |
KU Leuven |
|
Holen Ingunn |
University of Sheffield |
|
Ruprecht Karls University Heidelberg |
|
| Krysko Dmitri |
Universiteit Gent/VIB |
|
Perales Miguel-Angel |
Memorial Sloan Kettering Cancer Center |
|
Rahbari Nuh |
University of Mannheim/Heidelberg |
|
Smet Annemieke |
Universiteit Antwerpen |